Morgan Stanley’s Lixte Biotechnology LIXT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,106
| Closed | -$24K | – | 7915 |
|
|
2024
Q1 | $24K | Sell |
7,106
-7,106
| -50% | -$24K | ﹤0.01% | 6435 |
|
|
2023
Q4 | $33.4K | Buy |
14,212
+7,106
| +100% | +$16.7K | ﹤0.01% | 6490 |
|
|
2023
Q3 | $17.4K | Hold |
7,106
| – | – | ﹤0.01% | 6531 |
|
|
2023
Q2 | $41.8K | Sell |
7,106
-63,948
| -90% | -$376K | ﹤0.01% | 6281 |
|
|
2023
Q1 | $58.8K | Hold |
71,054
| – | – | ﹤0.01% | 6219 |
|
|
2022
Q4 | $36.2K | Hold |
71,054
| – | – | ﹤0.01% | 6430 |
|
|
2022
Q3 | $40K | Hold |
71,054
| – | – | ﹤0.01% | 6499 |
|
|
2022
Q2 | $53K | Hold |
71,054
| – | – | ﹤0.01% | 6581 |
|
|
2022
Q1 | $87K | Hold |
71,054
| – | – | ﹤0.01% | 6397 |
|
|
2021
Q4 | $85K | Hold |
71,054
| – | – | ﹤0.01% | 6530 |
|
|
2021
Q3 | $148K | Hold |
71,054
| – | – | ﹤0.01% | 6155 |
|
|
2021
Q2 | $215K | Buy |
71,054
+50,001
| +238% | +$151K | ﹤0.01% | 5977 |
|
|
2021
Q1 | $69K | Buy |
+21,053
| New | +$69K | ﹤0.01% | 6200 |
|